DUBLIN, Sept. 7, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/hltks7/the_new_saudi) has announced the addition of the "The New Saudi Arabian Pharmacovigilance Guidelines of June 2015, Dubai (Dubai, UAE - October 20-21 2015)" conference to their offering.
The new KSA pharmacovigilance guidelines were issued in May 2015 with their introduction on 27th June 2015. There are fundamental changes to Pharmacovigilance practice described in these guidelines which very much follow the EU guidelines, issued and implemented in June 2012. This intensive 2 day course will look at the various new topics and their practical application from the perspective of the introduction of the EU Guidelines. The course will include experiences of Inspections and audits following implementation and what the main focus points will be.
Graeme Ladds, Director of PharSafer, has over 22 years' experience working in the pharmaceutical industry. Having started his career at Ashbourne Pharmaceuticals in 1989 as Head of Drug Safety & Medical Information, Graeme went on to become Head of Global Pharmacovigilance at Shire Pharmaceuticals.
The last 11 years have been spent in his consultancy company, PharSafer Associates Ltd. During this time, Graeme has been involved in establishing pharmacovigilance in companies, performing audits across Europe and the USA, SOP writing, acting as QP for companies, and helping with regulatory inspections.
For more information visit
Laura Wood, +353-1-481-1716, email@example.com
SOURCE Research and Markets